# Gene	Alteration	Cancer Type	The highest FDA Level
# Level 1, 2 should be mapped to FDA Level 2			
# Level 3, 4 should be mapped to FDA Level 3			
BRAF	V600E	Melanoma	FDAx2
BRAF	Fusions	Melanoma	FDAx3
			
# Some special fda level 3 are from level 2			
EGFR	A763_Y764insFQEA	Non-Small Cell Lung Cancer	FDAx3

# oncogenic mutations should not be returned in the FDAAlteration list
ERBB2	Oncogenic Mutations	Non-Small Cell Lung Cancer	
BRAF	Oncogenic Mutations {excluding V600}	Langerhans Cell Histiocytosis	